Market capitalization | $0.00 |
Enterprise Value | $-12.78m |
EV/FCF (TTM) EV/FCF | 0.40 |
EV/Sales (TTM) EV/Sales | -0.54 |
P/S ratio (TTM) P/S ratio | 0.00 |
Revenue growth (TTM) Revenue growth | -28.57% |
Revenue (TTM) Revenue | $23.84m |
EBIT (operating result TTM) EBIT | $-31.70m |
Free Cash Flow (TTM) Free Cash Flow | $-32.12m |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
1 Analyst has issued a forecast MedAvail Holdings Inc:
1 Analyst has issued a forecast MedAvail Holdings Inc:
Jun '23 |
+/-
%
|
||
Revenue | 24 24 |
29%
29%
|
|
Gross Profit | -2.48 -2.48 |
520%
520%
|
|
EBITDA | -27 -27 |
40%
40%
|
EBIT (Operating Income) EBIT | -32 -32 |
33%
33%
|
Net Profit | -46 -46 |
5%
5%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
MedAvail Holdings, Inc. is a technology-enabled pharmacy company. It provides turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. The firm helps patients to optimize drug adherence, resulting in better health outcomes. The company is headquartered in Mississauga, Canada.
Head office | United States |
CEO | Mark Doerr |
Founded | 2007 |
Website | medavail.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.